Sun Pharmaceutical Industries Limited
SUNPHARMA.NS

$51.39 B
Marketcap
$21.42
Share price
Country
$-0.13
Change (1 day)
$22.85
Year High
$15.03
Year Low

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

marketcap

P/E ratio for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

P/E ratio as of 2023: 40.82

According to Sun Pharmaceutical Industries Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 40.82. At the end of 2022 the company had a P/E ratio of 27.84.

P/E ratio history for Sun Pharmaceutical Industries Limited from 2003 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 40.82
2022 27.84
2021 67.06
2020 49.39
2019 22.45
2018 43.10
2017 56.37
2016 23.75
2015 41.84
2014 54.25
2013 37.89
2012 28.26
2011 22.81
2010 25.23
2009 27.55
2008 12.26
2007 15.79
2006 23.63
2005 27.83
2004 21.61
2003 9.14